<?xml version="1.0" encoding="UTF-8"?>
<p>Although the mechanisms underlying CINV are not clear enough,
 <sup>[
  <xref rid="R9" ref-type="bibr">9</xref>]
 </sup> to date, commonly prescribed medicines,
 <sup>[
  <xref rid="R10" ref-type="bibr">10</xref>]
 </sup> for nausea and vomiting are: 5-hydroxytryptamine-3 serotonin receptor antagonists (5-HT3RA), Neurokinin1 receptor antagonists (NK-1RA), and corticosteroid.
 <sup>[
  <xref rid="R11" ref-type="bibr">11</xref>]
 </sup> However, for all its prominence in CINV management, these drugs are subject to considerably economic burden and side effects, namely insomnia, headaches, dizziness, and constipation.
 <sup>[
  <xref rid="R12" ref-type="bibr">12</xref>]
 </sup> Thus, additional treatments are urgently needed to effectively manage and ameliorate chemotherapy-induced nausea and vomiting (CINV), without those defects in the wake of antiemetic drugs.
</p>
